Standardizing Safety Analyses for Clinical Trials Across the Industry: A Story of Success in the Making
Date:
Poster Presentation
Presenting Author: Mohammad Fayaz
Authors: Mohammad Fayaz, Mary E. Nilsson
Conference: 35th Annual Conference of the International Society for Clinical Biostatistics (ISCB)
Vienna, Austria, 24–28 August 2014
DOI: https://doi.org/10.13140/2.1.3177.3448
Title
Standardizing Safety Analyses for Clinical Trials Across the Industry: A Story of Success in the Making
Abstract
Industry standards for clinical trial data management, including CDASH, SDTM, and ADaM, have significantly improved over time. However, further standardization is still required to enhance reproducibility, regulatory review efficiency, and consistency in clinical trial analysis.
This poster presents a cross-industry initiative led by the PhUSE Computational Science Symposium Working Group, which aims to develop standardized scripts for statistical analyses, tables, and figures across common clinical trial domains such as laboratory measurements, vital signs, electrocardiograms, adverse events, demographics, medications, and pharmacokinetics.
A centralized Script Repository has been developed to support reproducible research and collaborative statistical programming. The initiative promotes early detection of safety signals and improved characterization of drug safety profiles through standardized analytical workflows.
This work highlights the importance of collaborative development in clinical biostatistics and encourages broader adoption of reproducible and standardized analytical frameworks in pharmaceutical research.
